Will Erstad In 1995, she turned the CEO of Baxamed Corp. in Switzerland wherever integrative therapies were being offered such as fetal cell therapy, chelation treatment options, and hormone substitution therapy together with HGH. She developed the Plaquex protocol with her father that same year While using the goal of saving her mother’s existen… Read More